Current status of intra-cranial stereotactic radiotherapy and stereotactic radiosurgery in Australia and New Zealand: key considerations from a workshop and surveys.

Australia New Zealand Stereotactic radiosurgery Stereotactic radiotherapy Survey

Journal

Physical and engineering sciences in medicine
ISSN: 2662-4737
Titre abrégé: Phys Eng Sci Med
Pays: Switzerland
ID NLM: 101760671

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 30 09 2021
accepted: 20 01 2022
pubmed: 4 2 2022
medline: 11 3 2022
entrez: 3 2 2022
Statut: ppublish

Résumé

Recently, there has been increased interest worldwide in the use of conventional linear accelerator (linac)-based systems for delivery of stereotactic radiosurgery/radiotherapy (SRS/SRT) contrasting with historical delivery in specialised clinics with dedicated equipment. In order to gain an understanding and define the current status of SRS/SRT delivery in Australia and New Zealand (ANZ) we conducted surveys and provided a single-day workshop. Prior to the workshop ANZ medical physicists were invited to complete two surveys: a departmental survey regarding SRS/SRT practises and equipment; and an individual survey regarding opinions on current and future SRS/SRT practices. At the workshop conclusion, attendees completed a second opinion-based survey. Workshop discussion and survey data were utilised to identify areas of consensus, and areas where a community consensus was unclear. The workshop was held on the 8th Sept 2020 virtually due to pandemic-related travel restrictions and was attended by 238 radiation oncology medical physicists from 39 departments. The departmental survey received 32 responses; a further 89 and 142 responses were received to the pre-workshop and post-workshop surveys respectively. Workshop discussion indicated a consensus that for a department to offer an SRS/SRT service, a minimum case load should be considered depending on availability of training, peer-review, resources and equipment. It was suggested this service may be limited to brain metastases only, with less common indications reserved for departments with comprehensive SRS/SRT programs. Whilst most centres showed consensus with treatment delivery techniques and image guidance, opinions varied on the minimum target diameter and treatment margin that should be applied.

Identifiants

pubmed: 35113342
doi: 10.1007/s13246-022-01108-4
pii: 10.1007/s13246-022-01108-4
pmc: PMC8901507
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-259

Informations de copyright

© 2022. The Author(s).

Références

J Appl Clin Med Phys. 2016 Sep 08;17(5):184-199
pubmed: 27685124
BMC Cancer. 2016 Aug 19;16(1):659
pubmed: 27542716
Acta Oncol. 2019 Sep;58(9):1275-1282
pubmed: 31257960
Radiother Oncol. 2020 Jun;147:136-143
pubmed: 32294607
Med Phys. 2005 Jul;32(7Part1):2380-2398
pubmed: 28493584
Br J Neurosurg. 2002 Oct;16(5):477-82
pubmed: 12498492
J Med Imaging Radiat Oncol. 2015 Oct;59(5):646-53
pubmed: 26122017
J Clin Neurosci. 2017 Nov;45:48-53
pubmed: 28866073
World Neurosurg. 2020 Dec;144:e797-e806
pubmed: 32971279
Med Phys. 2008 Sep;35(9):4262-77
pubmed: 18841876
J Neurosurg. 2018 Apr 20;130(3):797-803
pubmed: 29676690
World Neurosurg. 2019 Feb;122:e1557-e1561
pubmed: 30471438
Br J Radiol. 2014 May;87(1037):20130681
pubmed: 24620840
J Neurosurg. 2016 Apr;124(4):1018-24
pubmed: 26473783
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):100-8
pubmed: 25442342
Expert Rev Anticancer Ther. 2018 Sep;18(9):887-900
pubmed: 29940802
J Med Phys. 2021 Jan-Mar;46(1):16-25
pubmed: 34267485
Cancer. 2011 Oct 1;117(19):4566-72
pubmed: 21412761
J Natl Compr Canc Netw. 2017 Dec;15(12):1494-1502
pubmed: 29223987
J Neurosurg. 2018 Dec 21;131(6):1848-1854
pubmed: 30579284
Radiat Oncol. 2018 Mar 5;13(1):38
pubmed: 29506539
Br J Radiol. 2013 Sep;86(1029):20130331
pubmed: 23873906
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):540-6
pubmed: 26460996
J Neurol Neurosurg Psychiatry. 1983 Sep;46(9):797-803
pubmed: 6352865
Expert Rev Anticancer Ther. 2016 Jul;16(7):731-40
pubmed: 27186849
Radiother Oncol. 2017 Jul;124(1):11-17
pubmed: 28687397
J Appl Clin Med Phys. 2017 Sep;18(5):10-21
pubmed: 28786239
Med J Aust. 2020 Jun;212(11):526-527
pubmed: 32249431
J Appl Clin Med Phys. 2018 Mar;19(2):111-120
pubmed: 29363282
BJR Open. 2019 Jul 19;1(1):20190022
pubmed: 33178949
Clin Oncol (R Coll Radiol). 2012 Nov;24(9):629-39
pubmed: 22633542
Phys Eng Sci Med. 2020 Jun;43(2):641-650
pubmed: 32524446
J Appl Clin Med Phys. 2018 Nov;19(6):99-108
pubmed: 30221462
J Med Imaging Radiat Oncol. 2019 Oct;63(5):711-720
pubmed: 31464070

Auteurs

Lauren Pudsey (L)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.

Annette Haworth (A)

Institute of Medical Physics, School of Physics, University of Sydney, Sydney, Australia.

Paul White (P)

Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Sydney, NSW, Australia.

Zoe Moutrie (Z)

Department of Radiation Oncology, Mater Hospital, GenesisCare, Crows Nest, Sydney, NSW, Australia.

Benjamin Jonker (B)

RPA Institute of Academic Surgery, University of Sydney, Sydney, Australia.

Matthew Foote (M)

University of Queensland, Princess Alexandra Hospital, ICON Cancer Care Queensland, Southport, Australia.

Joel Poder (J)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia. Joel.Poder@health.nsw.gov.au.
St George Hospital Cancer Care Centre, Kogarah, NSW, Australia. Joel.Poder@health.nsw.gov.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH